Diana
Hernandez Romero
Profesores Titulares de Universidad
![Foto de Diana](/img/uploaded/6145e560d44d3d4e0764a867fac47c92.jpeg)
![Foto de Hospital General Universitario de Alicante](/img/noimage_org.png)
Hospital General Universitario de Alicante
Alicante, EspañaPublications en collaboration avec des chercheurs de Hospital General Universitario de Alicante (17)
2019
-
Galectin-3 and β-trace protein concentrations are higher in clinically unaffected patients with Fabry disease
Scientific Reports, Vol. 9, Núm. 1
2016
-
Clinical implications of nonsarcomeric gene polymorphisms in hypertrophic cardiomyopathy
European Journal of Clinical Investigation, Vol. 46, Núm. 2, pp. 123-129
-
Long-term predictors of thromboembolic events in nonvalvular atrial fibrillation patients undergoing electrical cardioversion
Circulation Journal, Vol. 80, Núm. 3, pp. 605-612
2015
-
Effects of body mass index on the lipid profile and biomarkers of inflammation and a fibrinolytic and Prothrombotic state
Journal of Atherosclerosis and Thrombosis, Vol. 22, Núm. 6, pp. 610-617
-
Involvement of the -420C>G RETN polymorphism in myocardial fibrosis in patients with hypertrophic cardiomyopathy
Journal of Internal Medicine, Vol. 278, Núm. 1, pp. 50-58
2014
2013
-
Identification and confirmation of haptoglobin as a potential serum biomarker in hypertrophic cardiomyopathy using proteomic approaches
Annals of Medicine, Vol. 45, Núm. 4, pp. 341-347
-
Interleucina 6 y proteína C reactiva ultrasensible para la predicción de la evolución clínica en síndromes coronarios agudos sin elevación del segmento ST
Revista Espanola de Cardiologia, Vol. 66, Núm. 3, pp. 185-192
2012
-
Growth differentiation factor-15, a novel biomarker related with disease severity in patients with hypertrophic cardiomyopathy
European Journal of Internal Medicine, Vol. 23, Núm. 2, pp. 169-174
-
High-sensitivity troponin T and Copeptin in Non-ST acute coronary syndromes: Implications for prognosis and role of hsTnT and copeptin in non-STEACS
TheScientificWorldJournal, Vol. 2012
2011
2010
-
CALU A29809G polymorphism in coronary atherothrombosis: Implications for coronary calcification and prognosis
Annals of Medicine, Vol. 42, Núm. 6, pp. 439-446
-
Enzyme replacement therapy in fabry disease: Influence on cardiac manifestations
Current Medicinal Chemistry, Vol. 17, Núm. 16, pp. 1679-1689
-
Plasma levels of Von Willebrand factor are increased in patients with hypertrophic cardiomyopathy
Thrombosis Research, Vol. 126, Núm. 1
-
Serum Levels of high-sensitivity troponin T: A novel marker for cardiac remodeling in hypertrophic cardiomyopathy
Journal of Cardiac Failure, Vol. 16, Núm. 12, pp. 950-956
-
Synergism between factor XII -4C>T and factor XIII Val34Leu polymorphisms in fibrinolytic therapy in acute myocardial infarction
Thrombosis and Haemostasis
2009
-
Left atrial remodelling in hypertrophic cardiomyopathy: Relation with exercise capacity and biochemical markers of tissue strain and remodelling
International Journal of Clinical Practice, Vol. 63, Núm. 10, pp. 1465-1471